MediPoint: Total Hip Replacement - US Analysis and Market Forecasts

NEW YORK, Aug.迷你倉 28, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:MediPoint: Total Hip Replacement - US Analysis and Market Forecasts.reportlinker.com/p01605716/MediPoint-Total-Hip-Replacement---US-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=OrthopedicMediPoint: Total Hip Replacement - US Analysis and Market ForecastsSummaryOsteoarthritis has become a global public health concern with no cure. It is the most common form of arthritis that is primarily due to wear and tear of the joints. With the aging global population, this is an indication that is growing rapidly with the hip being one of the most common joints afflicted. While the primary indication for total hip replacement (THR) is osteoporosis, the other major indications for THR are osteonecrosis and fractures to a lesser degree. As people live longer and with younger patients also receiving implants, the revision rates for primary hip replacements are also expected to rise. Primary hip replacement has become one of the most successful surgeries, with a variety of femoral and acetabular components available from a wide selection of manufacturers. This report focuses on the total primary hip replacement market along with primary revision market. The global hip replacement market has been estimated in this report which includes the US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and compounded annual growth rates (CAGR).GlobalData's analysis shows that the hip replacement market has become a mature market where products have become commodities. The future of the market lays on the ability of manufacturers to provide implants at a very low cost while continuing to provide the same level of clinical efficacy. The product development need lies primarily in revising the resurfacing products' articulating surface with new materials rather than developing new acetabular and femoral components. Additionally the major opportunity lies within the emerging markets which are the countries that have a higher CAGR and will provide the key for growth and grabbing market share.The mature market in the design of hip replacement products has led to a shift in the focus of developing orthopedic implants. Orthopedic surgery in the hip has become more minimally invasive unlike that of the past, with smaller incision sizes, the development of computer-navigated arthroplasty systems and even bone-preserving techniques such as resurfacing. This report addresses the various unmet needs, presents the current technology and the drivers for the future and market growth in the US. Adoption rates are examined, as well as the decision-makers, in order capture market share.Scope- An overview of arthritis, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized US THR market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018. - Investigation of current and future market competition for THR- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the THR sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as Orthopedic SurgeonReasons to buy- Understand the trends shaping and driving the US THR Market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in the US THR market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. - Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth. - What's the next big thing in US THR market landscape? Identify, understand and capitalize.1 Table of Contents1 Table of Contents 71.1 List of Tables 161.2 List of Figures 262 Introduction 302.1 Catalyst 313 Disease Overview 333.1 Anatomy and Physiology 333.2 Pathophysiology 343.2.1 Overview 343.2.2 Osteoarthritis 343.2.3 Rheumatoid Arthritis 353.2.4 Post-traumatic Arthritis 363.2.5 Osteonecrosis 363.2.6 Injury 363.2.7 Bone Tumors 373.2.8 Other Diseases 373.3 Clinical Presentation 383.4 Clinical Outcomes 393.4.1 Overview 393.4.2 Conservative Therapy 413.4.3 Hip Arthroscopy 413.4.4 Hip Arthrodesis 423.4.5 Hemiarthroplasty (Partial) 433.4.6 Core Decompression 433.4.7 Hip Osteotomy 443.4.8 Resection Arthroplasty 443.4.9 Primary Total Hip Replacement 453.4.10 Revision Total Hip Replacement 473.4.11 Resurfacing Arthroplasty 483.4.12 Computer-Navigated Hip Replacement 493.5 Surgical Approaches 493.5.1 Anterolateral Approach 513.5.2 Posterior Approach 513.5.3 Direct Anterior Approach 523.5.4 Minimally Invasive Approaches 523.6 Epidemiology 533.6.1 US 543.7 Economic Impact 553.7.1 US 564 Competitive Assessment 584.1 Overview of Historical Designs 584.2 Marketed Products 594.2.1 Global Market Share 594.2.2 Primary Total Hip Replacement 614.2.3 Product Profiles by Company 615 Unmet Needs 2035.1 Long-Term Clinical Data 2035.2 Need for Continued Materials Research 2035.3 Bearings 2055.4 Refocus of Pipeline Products 2065.5 Renewal of Resurfacing 2075.6 Addressing the Learning Curve for Tier II Surgeons 2085.7 Need for Cost Containment 2105.8 Centralization 2115.9 National Joint Registry 2116 Pipeline Products 2136.1 Overview 2136.2 Primary Total Hip Pipeline Products 2136.2.1 Exactech LPI Prime Hip System 2136.2.2 EnduRo Bone-preserving Hip Stem 2146.2.3 Deltamotion Acetabular Cup System 2146.2.4 NovoSource Hip Implant 2157 Industry Overview 2167.1 Procedure Volumes 2167.1.1 US 2177.2 Market Access 2187.2.1 US 2187.3 Reimbursement Trends 2217.3.1 US 2217.4 Regulatory Issues/Recalls 2237.4.1 DePuy Hip Replacement Recall 2247.4.2 Stryker Hip Replacement Recall 2247.4.3 Smith & Nephew Recall: R3 Metal Liners of the R3 Acetabular System 2247.4.4 Zimmer Durom(R) Acetabular Component 2257.4.5 Biomet Hip Replacement Complications 2257.4.6 Wright Medical Conserve Hip Implant 2257.4.7 The Corin Group Metal-on-Metal Hip Resurfacing 2257.5 Mergers & Acquisitions / Key Partnerships 2267.5.1 Medtronic Acquires China Kanghui Holdings 2267.5.2 Tornier Acquires OrthoHelix Surgical Designs Inc. 2267.5.3 DePuy Orthopaedics (Johnson & Johnson) and Synthes Inc. Merge 2277.5.4 Italian Consortium 2IL Orthopaedics Ltd Acquires Corin Group 2277.5.5 Zimmer Acquires Beijing Montagne Medical Device Co. Ltd. 2277.5.6 Wright Medial Announces Agreement to Sell OrthoRecon Business to MicroPort Medical B.V. 2288 Company Profiles 2298.1 B. Braun 2298.1.1 Overview 2298.1.2 Portfolio Assessment 2308.1.3 SWOT Analysis 2308.2 Biomet Orthopedics 2318.2.1 Overview 2318.2.2 Portfolio Assessment 2328.2.3 SWOT Analysis 2358.3 Corentec Co. Ltd. 2368.3.1 Overview 2368.3.2 Portfolio Assessment 2368.3.3 SWOT Analysis 2378.4 Corin 2378.4.1 Overview 2378.4.2 Portfolio Assessment 2388.4.3 SWOT Analysis 2398.5 DePuy Synthes International 2408.5.1 Overview 2408.5.2 Portfolio Assessment 2418.5.3 SWOT Analysis 2448.6 Exactech 2448.6.1 Overview 2448.6.2 Portfolio Assessment 2458.6.3 SWOT Analysis 2478.7 Iconacy Orthopedic Implants LLC 2478.7.1 Overview 2478.7.2 Portfolio Assessment 2488.7.3 SWOT Analysis 2488.8 Implantcast GMBH 2498.8.1 Overview 2498.8.2 Portfolio Assessment 2498.8.3 SWOT Analysis 2518.9 JRI Orthopaedics 2518.9.1 Overview 2518.9.2 Portfolio Assessment 2528.9.3 SWOT Analysis 2538.10 Kyocera 2538.10.1 Overview 2538.10.2 Portfolio Assessment 2548.10.3 SWOT Analysis 2558.11 Limacorporate S.P.A 2558.11.1 Overview 2558.11.2 Portfolio Assessment 2568.11.3 SWOT Analysis 2578.12 Medacta 2588.12.1 Overview 2588.12.2 Portfolio Assessment 2588.12.3 SWOT Analysis 2598.13 Medtronic 2608.13.1 Overview 2608.13.2 Portfolio Assessment 2618.13.3 SWOT Analysis 2628.14 NovoSource Inc. 2628.14.1 Overview 2628.14.2 Portfolio Assessment 2638.14.3 SWOT Analysis 2648.15 Peter Brehm GMBH 2648.15.1 Overview 2648.15.2 Portfolio Assessment 2658.15.3 SWOT Analysis 2658.16 Serf Dedienne Sante 2668.16.1 Overview 2668.16.2 Portfolio Assessment 2678.16.3 SWOT Analysis 2688.17 Smith & Nephew 2688.17.1 Overview 2688.17.2 Portfolio Assessment 2698.17.3 SWOT Analysis 2718.18 Stelkast 2718.18.1 Overview 2718.18.2 Portfolio Assessment 2728.18.3 SWOT Analysis 2728.19 Stryker 2738.19.1 Overview 2738.19.2 Portfolio Assessment 2748.19.3 SWOT Analysis 2758.20 Tianjin Zhengtian Medical Instrument Co., Ltd. 2768.20.1 Overview 2768.20.2 Portfolio Assessment 2768.20.3 SWOT Analysis 2778.21 Tornier N.V. 2788.21.1 Overview 2788.21.2 Portfolio Assessment 2798.21.3 SWOT Analysis 2818.22 Wright Medical 2818.22.1 Overview 2818.22.2 Portfolio Assessment 2828.22.3 SWOT Analysis 2848.23 United Orthopedic Corporation 2858.23.1 Overview 2858.23.2 Portfolio Assessment 2858.23.3 SWOT Analysis 2868.24 Zimmer Holdings Inc. 2878.24.1 Overview 2878.24.2 Portfolio Assessment 2888.24.3 SWOT Analysis 2908.25 Other Companies 2919 Market Drivers, Opportunities and Barriers 2929.1 Market Drivers 2929.1.1 Prevalence Rise 2929.1.2 Expanding Indications 2949.1.3 Availability and Lack of Long-Term Clinical Data 2959.1.4 Fracture Incidence 2959.1.5 Patient Demand and Awareness 2959.2 Opportunities 2969.2.1 Revision Surgery 2969.2.2 Emerging Markets 2969.2.3 Continued Materials Research 2979.2.4 Corporate Promotions and Teaching Seminars 2989.2.5 Advancement towards Cost Reduction 2989.3 Market Barriers 2999.3.1 Market Barriers 29910 Country Outlooks & Forecasts 30310.1 US Market Analysis 30311 Appendix 30711.1 Abbreviations 30711.2 Bibliography 30811.3 Report Methodology 32511.3.1 Overview 32511.3.2 Coverage 32511.3.3 Secondary Research 32611.3.4 Forecasting Methodology 32711.3.5 Primary Research - Key Opinion Leader Interviews 32811.3.6 Expert Panel Validation 32811.4 Physicians and Specialists Included in this Study 32911.4.1 Dr. Alessandro Aprato 32911.4.2 Dr. Fran Channa 32911.4.3 Joseph Daniel FRCS MS (Orth) 32911.4.4 Dr. Alejandro Gonzalez Della Valle 32911.4.5 Dr. Moussa Hamadouche 32911.4.6 Dr. Sheng-Li Huang and Xi-Jing He 32911.4.7 Dr. Ayumi Kaneuji 32911.4.8 Dr. Yuichi Mitani 32911.4.9 Dr. Ning Lu 33011.4.10 Dr. Deepak Saini 33011.4.11 Dr. Lafayette Lage 33011.4.12 Dr. Christoph Zilkens 33011.5 About the Authors 33111.5.1 Analysts 33111.5.2 Global Head of Healthcare 33211.6 About MediPoint 33311.7 About GlobalData 33311.8 Disclaimer 3331.1 List of Tables Table 1: Clinical Symptoms and Descriptions 38Table 2: Advantages and Disadvantages of Hip Resurfacing 48Table 3: Surgical Approaches Comparison 49Table 4: Direct and Indirect Costs of Arthritis 55Table 5: Bicontact Universal Hip System (B. Braun) 63Table 6: Clinical Studies Bicontact Universal Hip System (B. Braun) 64Table 7: SWOT Bicontact Universal Hip System 64Table 8: Excia Hip Stem (B. Braun) 66Table 9: Clinical Studies Excia Hip Stem (B. Braun) 67Table 10: SWOT Excia Hip Stem 67Table 11: Metha(R) Short Hip Stem (B. Braun) 69Table 12: Clinical Studies Metha(R) Short Hip Stem (B. Braun) 70Table 13: SWOT Metha(R) Short Hip Stem 70Table 14: TRJ Cementless Hip Endoprosthesis System (B. Braun) 72Table 15: SWOT TRJ Cementless Hip Endoprosthesis System 73Table 16: Plasmacup SC Acetabular Cup (B. Braun) 74Table 17: Balance Femoral Component (Biomet) 76Table 18: Clinical Studies Balance Femoral Component (Biomet) 76Table 19: SWOT Balance Femoral Component 77Table 20: Bi-Metric Femoral Components (Biomet) 78Table 21: Clinical Studies Bi-Metric Femoral Components (Biomet) 78Table 22: SWOT Bi-Metric Femoral Components 79Table 23: Bio-Moore II Hip System (Biomet) 80Table 24: Clinical Studies Bio-Moore II Hip System (Biomet) 80Table 25: SWOT Bio-Moore II Hip System 81Table 26: Generation 4 Polished Hip System (Biomet) 82Table 27: SWOT Generation 4 Polished Hip System 82Table 28: Integral Porous Primary Hip System (Biomet) 84Table 29: Clinical Studies Integral Porous Hip System (Biomet) 84Table 30: SWOT Integral Porous Hip System Femoral Components 85Table 31: Mallory Femoral Component (Biomet) 86Table 32: Clinical Studies Mallory Femoral Component (Biomet) 87Table 33: SWOT Mallory Femoral Component 87Table 34: Progressive Total Hip System (Biomet) 88Table 35: SWOT Progressive Total Hip System 89Table 36: Rx 90 Smooth Primary Femoral Component (Biomet) 90Table 37: SWOT Rx 90 Smooth Primary Femoral Component 90Table 38: Stanmore Hip System (Biomet) 92Table 39: Clinical Studies Stanmore Hip System (Biomet) 92Table 40: SWOT Stanmore Hip System 93Table 41: Taperloc and Balance Microplasty Hip Stems (Biomet) 94Table 42: Clinical Studies Taperloc and Balance Microplasty Hip Stems (Biomet) 94Table 43: SWOT Taperloc and Balance Microplasty Hip Stems 95Table 44: Acetabular Systems (Biomet) 95Table 45: Bencox Stems (Corentec Co. Ltd) 97Table 46: Clinical Studies Bencox Stems (Corentec Co. Ltd) 97Table 47: SWOT Bencox Stems 98Table 48: Bencox Acetabular Systems (Corentec Co. Ltd.) 99Table 49: MetaFix (Corin) 100Table 50: SWOT MetaFix 100Table 51: MiniHip (Corin) 102Table 52文件倉 SWOT MiniHip 102Table 53: MRP-Titan (Corin) 104Table 54: SWOT MRP-Titan 104Table 55: TaperFit (Corin) 106Table 56: SWOT TaperFit 106Table 57: Trinity Acetabular System (Corin) 108Table 58: Cenator Acetabular Cup (Corin) 109Table 59: Cementless Systems (DePuy Synthes) 111Table 60: Clinical Studies Cementless Systems (DePuy Synthes) 111Table 61: SWOT DePuy Synthes Cementless Systems 112Table 62: Cemented Systems (DePuy Synthes) 113Table 63: Clinical Studies Cemented Systems (DePuy Synthes) 113Table 64: SWOT DePuy Synthes Cemented Systems 113Table 65: DePuy Synthes Acetabular Systems (DePuy Synthes) 115Table 66: AcuMatch Femoral Stems (Exactech) 116Table 67: Clinical Studies AcuMatch Femoral Stems (Exactech) 117Table 68: SWOT AcuMatch Femoral Stems 117Table 69: Novation Femoral Stems (Exactech) 119Table 70: Clinical Studies Novation Femoral Stems (Exactech) 119Table 71: SWOT Novation Femoral Stems 120Table 72: Exactech Acetabular Systems (Exactech) 120Table 73: i-Hip Total Hip Implant (Iconacy Orthopedic Implants) 122Table 74: SWOT i-Hip Total Hip Implant 122Table 75: EcoFit Femoral Stem (Implantcast GMBH) 124Table 76: Aida Short Femoral Stem (Implantcast GMBH) 125Table 77: AJS Hip System (Implantcast GMBH) 126Table 78: DiaLoc Hip Stem (Implantcast GMBH) 127Table 79: LOAD SHIFT Hip Stem (Implantcast GMBH) 128Table 80: Ceraco Hip Stem (Implantcast GMBH) 129Table 81: IC Straight Stem Type I and Type II (Implantcast GMBH) 130Table 82: Bicana Hip Stem (Implantcast GMBH) 131Table 83: SWOT Implantcast GMBH Femoral Stems 131Table 84: Implantcast GMBH Acetabular Cups (Implantcast GMBH) 133Table 85: Aeon Hip System (JRI Orthopaedics) 134Table 86: SWOT Aeon Hip System 134Table 87: Furlong Hip System and Evolution System (JRI Orthopaedics) 135Table 88: Clinical Studies Furlong Hip System (JRI Orthopaedics) 136Table 89: SWOT Furlong Hip System and Evolution System 136Table 90: Limacorporate Cementless Femoral Stems (Limacorporate SPA) 138Table 91: SWOT Limacorporate Cementless Femoral Stems 138Table 92: Cemented and Cementless Stems (Limacorporate SPA) 140Table 93: SWOT Cemented and Cementless Stems (Limacorporate SPA) 140Table 94: Limacorporate Acetabular Systems 141Table 95: Cemented and Cementless Stems (Medacta) 143Table 96: SWOT Medacta Stems 143Table 97: Acetabular Cups and Femoral Heads (Medacta) 144Table 98: Helicon Hip System (TGM Medical, wholly owned by Medtronic) 145Table 99: SWOT Helicon Hip System 146Table 100: Vektor Titan and Vektor CoCr (Peter Brehm GMBH) 148Table 101: Clinical Studies Peter Brehm Stems (Peter Brehm GMBH) 148Table 102: SWOT Peter Brehm Products 149Table 103: Libra and Sagittal EVL (Serf Dedienne Sante) 151Table 104: SWOT Libra and Sagittal EVL 151Table 105: Acetabular Cups (Serf Dedienne Sante) 153Table 106: Echelon and Synergy (Smith & Nephew) 155Table 107: SWOT Echelon and Synergy 155Table 108: Anthology Hip System (Smith & Nephew) 156Table 109: SWOT Anthology Hip System 157Table 110: CPCS and Spectron Hip System (Smith & Nephew) 158Table 111: SWOT CPCS and Spectron Hip System 158Table 112: Emperion and SMF Modular Stems (Smith & Nephew) 159Table 113: SWOT Emperion and SMF Modular Stems 160Table 114: Acetabular Cups (Smith & Nephew) 161Table 115: ProClass Hip Stem (Stelkast) 162Table 116: SWOT ProClass Hip Stem 162Table 117: Progeny Hip Stem (Stelkast) 163Table 118: SWOT Progeny Hip Stem 164Table 119: Protract Hip Stem (Stelkast) 165Table 120: SWOT Protract Hip Stem 165Table 121: Provident Hip Stem (Stelkast) 166Table 122: SWOT Provident Hip Stem 167Table 123: Acetabular Cups (Stelkast) 169Table 124: Cementless Stems (Stryker) 171Table 125: SWOT Cementless Stems 171Table 126: Cemented Stems (Stryker) 172Table 127: SWOT Cemented Stems 173Table 128: Acetabular Systems (Stryker) 174Table 129: Diamond Total Hip Implant (Tianjin Zhengtian Medical Instruments) 175Table 130: SWOT Diamond Total Hip Implant 175Table 131: Linea Stem (Tornier N.V.) 177Table 132: SWOT Linea Stem 178Table 133: Meije Duo Stem (Tornier N.V.) 179Table 134: SWOT Meije Duo Stem 180Table 135: Oceane Stem (Tornier N.V.) 181Table 136: SWOT Oceane Stem 182Table 137: Tornier Femoral Heads (Tornier N.V.) 183Table 138: Oceane Cup (Tornier N.V.) 184Table 139: Tornier Dynacup (Tornier N.V.) 185Table 140: Tornier Dual Mobility (Tornier N.V.) 186Table 141: Perfecta Cementless and Cemented Stems (Wright Medical) 187Table 142: SWOT Perfecta Cementless and Cemented Stems 188Table 143: Cementless Femoral Stems (Wright Medical) 190Table 144: SWOT Cementless Femoral Stems 191Table 145: Cemented Femoral Stems (Wright Medical) 192Table 146: SWOT Cemented and Cementless Femoral Stems (Wright Medical) 192Table 147: Acetabular Systems (Wright Medical) 194Table 148: UTF and UTF Reduced Stem (United Orthopedic Company) 195Table 149: SWOT UTF and UTF Reduced Stem 196Table 150: Hip U1 and U2 Stems (United Orthopedic Corporation) 197Table 151: SWOT Acetabular Systems (United Orthopedic Corporation) 197Table 152: Acetabular Systems (United Orthopedic Corporation) 198Table 153: Press-Fit Stems (Zimmer Holdings Inc.) 200Table 154: SWOT Press-Fit Stems 200Table 155: Acetabular Systems (Zimmer Holdings Inc.) 202Table 156: Exactech LPI Prime Hip System (Exactech) 214Table 157: Company Profile - B. Braun 229Table 158: B. Braun Product Portfolio 230Table 159: SWOT Analysis - B. Braun 230Table 160: Company Profile - Biomet Orthopedics 231Table 161: Biomet Product Portfolio 233Table 162: SWOT Analysis - Biomet Orthopedics 235Table 163: Company Profile - Corentec Co. Ltd. 236Table 164: Corentec Product Portfolio 236Table 165: SWOT Analysis - Corentec Co. Ltd. 237Table 166: Company Profile - Corin Group 238Table 167: Corin Group Product Portfolio 239Table 168: SWOT Analysis - Corin Group 239Table 169: Company Profile - DePuy Synthes International 241Table 170: DePuy Synthes International Product Portfolio 242Table 171: SWOT Analysis - DePuy Synthes International 244Table 172: Company Profile - Exactech 245Table 173: Exactech Product Portfolio 246Table 174: SWOT Analysis - Exactech 247Table 175: Company Profile - Iconacy Orthopedic Implants LLC 247Table 176: Iconacy Orthopedic Implants LLC Product Portfolio 248Table 177: SWOT Analysis - Iconacy Orthopedic Implants LLC 248Table 178: Company Profile - Implantcast GMBH 249Table 179: Implantcast GMBH Product Portfolio 250Table 180: SWOT Analysis - Implantcast GMBH 251Table 181: Company Profile - JRI Orthopaedics 251Table 182: JRI Orthopaedics Product Portfolio 252Table 183: SWOT Analysis - JRI Orthopaedics 253Table 184: Company Profile - KYOCERA Medical Corporation 254Table 185: KYOCERA Medical Corporation Product Portfolio 254Table 186: SWOT Analysis - KYOCERA Medical Corporation 255Table 187: Company Profile - Limacorporate S.P.A 256Table 188: Limacorporate S.P.A Product Portfolio 256Table 189: SWOT Analysis - Limacorporate S.P.A 257Table 190: Company Profile - Medacta International 258Table 191: Medacta International Product Portfolio 259Table 192: SWOT Analysis - Medacta International 259Table 193: Company Profile - Medtronic 260Table 194: Medtronic Product Portfolio 261Table 195: SWOT Analysis - Medtronic 262Table 196: Company Profile - NovoSource Inc. 263Table 197: NovoSource Inc. Product Portfolio 263Table 198: SWOT Analysis - NovoSource Inc. 264Table 199: Company Profile - Peter Brehm GMBH 264Table 200: Peter Brehm GMBH Product Portfolio 265Table 201: SWOT Analysis - Peter Brehm GMBH 265Table 202: Company Profile - Serf Dedienne Sante 266Table 203: Serf Dedienne Sante Product Portfolio 267Table 204: SWOT Analysis - Serf Dedienne Sante 268Table 205: Company Profile - Smith & Nephew 269Table 206: Smith & Nephew Product Portfolio 270Table 207: SWOT Analysis - Smith & Nephew 271Table 208: Company Profile - Stelkast 271Table 209: Stelkast Product Portfolio 272Table 210: SWOT Analysis - Stelkast 272Table 211: Company Profile - Stryker 274Table 212: Stryker Product Portfolio 275Table 213: SWOT Analysis - Stryker 275Table 214: Company Profile - Tianjin Zhengtian Medical Instrument Co. Ltd. 276Table 215: Tianjin Zhengtian Medical Instrument Co. Ltd. Product Portfolio 277Table 216: SWOT Analysis - Tianjin Zhengtian Medical Instrument Co. Ltd. 277Table 217: Company Profile - Tornier N.V. 279Table 218: Tornier N.V. Product Portfolio 280Table 219: SWOT Analysis - Tornier N.V. 281Table 220: Company Profile - Wright Medical 282Table 221: Wright Medical Product Portfolio 283Table 222: SWOT Analysis - Wright Medical 284Table 223: Company Profile - United Orthopedic Corporation 285Table 224: United Orthopedic Corporation Product Portfolio 286Table 225: SWOT Analysis - United Orthopedic Corporation 286Table 226: Company Profile - Zimmer Holdings Inc. 288Table 227: Zimmer Holdings Inc. Product Portfolio 289Table 228: SWOT Analysis - Zimmer Holdings, Inc. 290Table 229: Other Companies in the Global Hip Replacement Market 291Table 230: US Sales ($m) Forecast for THR, 2010-2019 3051.2 List of FiguresFigure 1: Anatomy of the Hip 33Figure 2: Treatment Paradigm for Hip Osteoarthritis 39Figure 3: Treatment Paradigm for Hip Fractures 40Figure 4: Hip Arthrodesis 42Figure 5: Partial Hip Arthroplasty and Total Hip Arthroplasty 46Figure 6: Surgical Approach Used by Orthopedic Surgeons Globally 50Figure 7: Surgical Approach Used by Orthopedic Surgeons in North America 50Figure 8: Population with Osteoarthritis in the US, 2010-2019 54Figure 9: Costs Related to Total Hip Replacement 57Figure 10: Global Market Share for Reconstructive Products, 2012 59Figure 11: US Market Share for Hip Replacement Products, 2010 60Figure 12: Bicontact Universal Hip System (B. Braun) 62Figure 13: Excia Hip Stem (B. Braun) 65Figure 14: Metha(R) Short Hip Stem (B. Braun) 68Figure 15: TRJ Cementless Hip Endoprosthesis System (B. Braun) 71Figure 16: Plasmacup SC Acetabular Cup (B. Braun) 74Figure 17: Balance Femoral Component (Biomet) 75Figure 18: Bi-Metric Femoral Components (Biomet) 77Figure 19: Bio-Moore II Hip System (Biomet) 79Figure 20: Generation 4 Polished Hip System (Biomet) 81Figure 21: Integral Porous Primary Hip System (Biomet) 83Figure 22: Mallory Femoral Component (Biomet) 86Figure 23: Progressive Total Hip System (Biomet) 88Figure 24: Rx 90 Smooth Primary Femoral Component (Biomet) 89Figure 25: Stanmore Hip System (Biomet) 91Figure 26: Taperloc and Balance Microplasty Hip Stems (Biomet) 93Figure 27: Bencox Stems (Corentec Co. Ltd) 96Figure 28: Bencox Acetabular Systems (Corentec Co. Ltd.) 98Figure 29: MetaFix (Corin) 99Figure 30: MiniHip (Corin) 101Figure 31: MRP-Titan (Corin) 103Figure 32: TaperFit (Corin) 105Figure 33: Trinity Acetabular System (Corin) 107Figure 34: Cenator Acetabular Cup (Corin) 109Figure 35: Cementless Systems (DePuy Synthes) 110Figure 36: Cemented Systems (DePuy Synthes) 112Figure 37: DePuy Acetabular Systems (DePuy Synthes) 114Figure 38: AcuMatch Femoral Stems (Exactech) 116Figure 39: Novation Femoral Stems (Exactech) 118Figure 40: i-Hip Total Hip Implant (Iconacy Orthopedic Implants) 121Figure 41: EcoFit Femoral Stem (Implantcast GMBH) 123Figure 42: Aida Short Femoral Stem (Implantcast GMBH) 124Figure 43: AJS Hip System (Implantcast GMBH) 125Figure 44: DiaLoc Hip Stem (Implantcast GMBH) 126Figure 45: LOAD SHIFT Hip Stem (Implantcast GMBH) 127Figure 46: Ceraco Hip Stem (Implantcast GMBH) 128Figure 47: IC Straight Stem Type I and Type II (Implantcast GMBH) 129Figure 48: Bicana Hip Stem (Implantcast GMBH) 130Figure 49: Implantcast GMBH Acetabular Cups (Implantcast GMBH) 132Figure 50: Aeon Hip System (JRI Orthopaedics) 133Figure 51: Furlong Hip System and Evolution System (JRI Orthopaedics) 135Figure 52: Cemented and Cementless Stems (Limacorporate SPA) 139Figure 53: Cemented and Cementless Stems (Medacta) 142Figure 54: Helicon Hip System (TGM Medical wholly owned by Medtronic) 145Figure 55: Vektor-Titan and Vektor-CoCr (Peter Brehm GMBH) 147Figure 56: Libra and Sagitta EVL (Serf Dedienne Sante) 150Figure 57: Acetabular Cups (Serf Dedienne Sante) 152Figure 58: Echelon and Synergy (Smith & Nephew) 154Figure 59: Anthology Hip System (Smith & Nephew) 156Figure 60: CPCS and Spectron Hip System (Smith & Nephew) 157Figure 61: Emperion and SMF Modular Stems (Smith & Nephew) 159Figure 62: Acetabular Cups (Smith & Nephew) 160Figure 63: ProClass Hip Stem (Stelkast) 161Figure 64: Progeny Hip Stem (Stelkast) 163Figure 65: Protract Hip Stem (Stelkast) 164Figure 66: Provident Hip Stem (Stelkast) 166Figure 67: Acetabular Systems (Stelkast) 168Figure 68: Cementless Stems (Stryker) 170Figure 69: Cemented Stems (Stryker) 172Figure 70: Acetabular Systems (Stryker) 173Figure 71: Diamond Total Hip Implant (Tianjin Zhengtian Medical Instruments) 174Figure 72: Linea Stem (Tornier N.V.) 176Figure 73: Meije Duo Stem (Tornier N.V.) 178Figure 74: Oceane Stem (Tornier N.V.) 180Figure 75: Tornier Femoral Heads (Tornier N.V.) 182Figure 76: Oceane Cup (Tornier N.V.) 183Figure 77: Tornier Dynacup (Tornier N.V.) 185Figure 78: Tornier Dual Mobility (Tornier N.V.) 186Figure 79: Perfecta Cementless and Cemented Stems (Wright Medical) 187Figure 80: Cementless Femoral Stems (Wright Medical) 189Figure 81: Profemur Gladiator (Wright Medical) 191Figure 82: Acetabular Systems (Wright Medical) 193Figure 83: UTF and UTF Reduced Stem (United Orthopedic Corporation) 195Figure 84: Hip U1 and U2 Stems (United Orthopedic Corporation) 196Figure 85: Acetabular Systems (United Orthopedic Corporation) 198Figure 86: Press-Fit Stems (Zimmer Holdings Inc.) 199Figure 87: Acetabular Systems (Zimmer Holdings Inc.) 201Figure 88: US Primary Hip Arthroplasty Procedure Volumes (2010-2019) 217Figure 89: Arthroplasty Cost Breakdown With Patient Discharged Home (2007) 219Figure 90: Medicare Payment Trend for Hip and Knee Joint Replacement, 1985-2009 223Figure 91: US Sales ($m) Forecast for THR, 2010-2019 306Companies MentionedB. Braun Biomet OrthopedicsCorentec Co. Ltd.Corin DePuy Synthes InternationalExactech Iconacy Orthopedic Implants LLCImplantcast GMBHJRI OrthopaedicsKyocera Limacorporate S.P.AMedacta Medtronic NovoSource Inc.Peter Brehm GMBHSerf Dedienne SanteSmith & NephewStelkast Stryker Tianjin Zhengtian Medical Instrument Co., Ltd.Tornier N.V. Wright Medical United Orthopedic CorporationZimmer Holdings Inc.Other CompaniesTo order this report:Orthopedic Industry: MediPoint: Total Hip Replacement - US Analysis and Market ForecastsContact Clare: clare@reportlinker.com US:(339) 368 6001Intl:+1 339 368 6001ReportlinkerWeb site: .reportlinker.com/存倉